Indication
Infantile malignant osteopetrosis
Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation. Read more about Infantile malignant osteopetrosis
3 drugs 3 manufacturers
Drugs that treat it
Common Infantile malignant osteopetrosis therapies.
ACTIMMUNE (interferon gamma-1b,recomb.)
ACTIMMUNE (interferon gamma-1b,recomb.)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInfantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation.
Manifesting in the neonatal period or early infancy, this condition severely impacts both the skeletal and hematopoietic systems.
Failure of the marrow cavities to develop results in progressive bone marrow failure presenting with pancytopenia, severe anemia, recurrent infections, and compensatory hepatosplenomegaly.
Additionally, hyperostosis and progressive narrowing of the cranial foramina compress traversing cranial nerves, frequently causing optic atrophy, blindness, sensorineural hearing loss, and facial nerve palsy.
Without intervention, the disease follows a rapidly progressive, life-threatening course.
- nih.gov
Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation Manifesting in the neonatal period or early infancy, this condition severely impacts both the skeletal and hematopoietic systems Failure of the marrow cavities to develop results in progressive bone marrow failure presenting with pancytopenia, severe anemia, recurrent infecti...
- medlineplus.gov
Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation Manifesting in the neonatal period or early infancy, this condition severely impacts both the skeletal and hematopoietic systems Failure of the marrow cavities to develop results in progressive bone marrow failure presenting with pancytopenia, severe anemia, recurrent infecti...
- nih.gov
Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation
- nih.gov
Manifesting in the neonatal period or early infancy, this condition severely impacts both the skeletal and hematopoietic systems
- nih.gov
Failure of the marrow cavities to develop results in progressive bone marrow failure presenting with pancytopenia, severe anemia, recurrent infections, and compensatory hepatosplenomegaly Without intervention, the disease follows a rapidly progressive, life-threatening course
- nih.gov
Additionally, hyperostosis and progressive narrowing of the cranial foramina compress traversing cranial nerves, frequently causing optic atrophy, blindness, sensorineural hearing loss, and facial nerve palsy Without intervention, the disease follows a rapidly progressive, life-threatening course
Personalize your experience
Follow Infantile malignant osteopetrosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.